![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Hu Miao Tomlinson Brian
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.14, Iss.8, 2013-06, pp. : 981-995
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lipid-lowering therapies in development
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lipid-lowering therapy in diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of Lipid-Lowering Pharmacotherapy in Children
By Tonstad S.
Pediatric Drugs, Vol. 2, Iss. 1, 2000-01 ,pp. :